Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

immunoconjugate

(IH-myoo-noh-KON-jih-gut)
An agent made up of an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance such as a toxin, a radioactive molecule, or a drug. The antibody part of the immunoconjugate targets cancer cells and the linked substance may kill the cells or make them visible in the body. Some immunoconjugates are used to treat cancer or to help find cancer cells in the body.
Search NCI's Dictionary of Cancer Terms